What is Prellis Biologics worth?
$110.1Mlast known valuation
Prellis Biologics last raised $17.0M in its Early Stage VC (Jun 2022).
Free account
See the evidence behind this price
- ·Post-money valuations for all 5 rounds
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for Prellis Biologics
Create free account
No card required
Funding history
5 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jun 2022 | Early Stage VC | $17.0M | ▮ | ▮ |
| Jul 2021 | Early Stage VC | $19.3M | ▮ | ▮ |
| Mar 2019 | Early Stage VC | $8.7M | ▮ | ▮ |
| Jan 2018 | Seed Round | $460K | ▮ | ▮ |
| Jun 2017 | Seed Round | $1.8M | ▮ | ▮ |
How Prellis Biologics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Prellis Biologics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Prellis Biologics worth?
- Prellis Biologics's last known valuation is $110.1M.
- How much has Prellis Biologics raised?
- Prellis Biologics has raised $70.2M in total funding across 5 recorded rounds.
- When did Prellis Biologics last raise?
- Prellis Biologics last raised in Jun 2022 (Early Stage VC), raising $17.0M.